Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Benign hereditary chorea (BHC) is a rare movement disorder that beginsin infancy or childhood. Signs and symptoms in infants may include low muscle tone, involuntary movements (chorea), lung infections, and respiratory distress. Signs and symptoms in children may include delayed motor and walking milestones, jerky muscle movements (myoclonus), upper limb dystonia, motor tics, and vocal tics. The chorea often improves with time. In some cases, myoclonus persists or worsens. Children with BHC can havenormal intellect, but may have learning and behavior problems. Other signs and symptoms include thyroid problems (e.g., hypothyroidism) and lung disease (e.g., recurring infections). Treatment is tailored to each child. Tetrabenazine and levodopa have been tried in individual cases with some success. BHC is caused by mutations in the NKX2-1 gene (also known as the TITF1 gene). It is passed through families in an autosomal dominant fashion.
Features include: Chorea.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 1 | Chorea |
No clinical trials have been registered for chorea, benign familial.
8 publications have been identified in PubMed for chorea, benign familial. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (38%), and Epidemiology / Natural History (13%).
Nou-Fontanet L (2026). [PMID: 41552915](https://pubmed.ncbi.nlm.nih.gov/41552915/). *Movement disorders : official journal of the Movement Disorder Society*. [Epidemiology / Natural History]
Aloisio S (2025). [PMID: 41423511](https://pubmed.ncbi.nlm.nih.gov/41423511/). *Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology*. [Case Report / Case Series]
Wu R (2025). [PMID: 41053704](https://pubmed.ncbi.nlm.nih.gov/41053704/). *BMC pediatrics*. [Case Report / Case Series]
Michel K (2025). [PMID: 40395234](https://pubmed.ncbi.nlm.nih.gov/40395234/). *Frontiers in medicine*. [Review / Meta-Analysis]
Pérez-Pérez J (2025). [PMID: 41104576](https://pubmed.ncbi.nlm.nih.gov/41104576/). *European journal of neurology*. [Review / Meta-Analysis]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 10:00 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Vercammen J (2024). [PMID: 38454250](https://pubmed.ncbi.nlm.nih.gov/38454250/). *Movement disorders clinical practice*. [Case Report / Case Series]
Kurzbuch AR (2024). [PMID: 39604647](https://pubmed.ncbi.nlm.nih.gov/39604647/). *Neurosurgical review*. [Case Report / Case Series]
Skwara J (2024). [PMID: 38916623](https://pubmed.ncbi.nlm.nih.gov/38916623/). *Journal of neural transmission (Vienna, Austria : 1996)*. [Review / Meta-Analysis]
AI-curated news mentioning chorea, benign familial
Updated Jul 14, 2026
An expert consensus has been published outlining practical recommendations for treating chorea associated with Huntington's disease. This guidance aims to improve management strategies for patients experiencing this movement disorder.
A new publication discusses the genetic causes of cerebellar ataxia and chorea, emphasizing critical factors for diagnosis and management. This research highlights the importance of understanding genetic etiology in improving patient outcomes.